Non-Subsidised LPG Prices Reduced By Over Rs 100 Per Cylinder From Today: 5 Things To Know
LPG or cooking gas prices were reduced with effect from July 1, 2019, reversing a rising trend in the past four months. In Delhi and Mumbai, the prices of non-subsidised LPG cylinders were lowered by Rs 100.5 per cylinder (14.2 kilograms) and Rs 101 per cylinder respectively, data from Indian Oil Corporation showed. State-run Indian Oil supplies LPG under brand Indane. The subsidised LPG cylinder price was lowered by Rs 3.02 per cylinder and Rs 3.05 per cylinder in Delhi and Mumbai, respectively.
Here are 10 things to know about LPG (cooking gas) cylinder prices today:
1. The non-subsidised LPG price has been revised to Rs 637 per cylinder in Delhi, Rs 662.5 per cylinder in Kolkata, Rs 608.5 per cylinder in Mumbai and Rs 652.5 per cylinder in Chennai from July 1.
2. That meant a cut of Rs 100.5 per cylinder each in Delhi and Chennai, and Rs 101 per cylinder each in Kolkata and Mumbai.
3. With effect from July 1, subsidised LPG rates stand at Rs 494.35 per cylinder in Delhi, Rs 497.47 per cylinder in Kolkata, Rs 492.04 per cylinder in Mumbai and Rs 482.23 per cylinder in Chennai.
4. That marks a reduction to the tune of Rs 3.02 per cylinder in subsidised LPG rates each in Delhi and Chennai compared to the previous month. In Mumbai and Kolkata each, the LPG price is down Rs 3.05 per cylinder compared to the previous month.
5. Currently, the government subsidises 12 cylinders of 14.2 kilograms each per household in a year. For any additional purchases, the consumer has to bear the market price. The amount of subsidy varies from month to month depending on the changes in the average international benchmark LPG prices and foreign exchange rates.
-
Getting To Work Costs Women More | The Reason Why
It is not just about women paying more than men. It is about women paying much more in cities than in villages.
-
AI Bias In Investing Cannot Be Eliminated, But It Can Be Governed
Framing is a particularly important example as identical financial information presented in terms of gains rather than losses can lead an LLM to reach a different assessment.
-
Joining The Dots | Dark Skies, Steady Diya: Why Hope Holds This Diwali
With war, a weak rupee and foreign outflows weighing on sentiment, policymakers at the NDTV World Summit and market veterans at NDTV Profit Ignite: Diwali Edition offered the same advice: stay invested and filter out the noise.
-
The Curious Case of Equitas Small Finance Bank And A CEO Who Quit For Stock
PN Vasudevan believes persistent investor concerns over a perceived conflict of interest had become a governance overhang on Equitas Small Finance Bank's stock, even as the lender improved profitability and asset quality.
-
Talking Points This Week: AI Cash Burn, A Tiger Comeback And An India That Still Finds Its Own Path
India is not immune to higher oil or tighter global liquidity, yet its earnings base is broader, its domestic policy levers are still available.
-
Foreign Investors Own Half Of HDFC Bank and ICICI Bank. An LTCG Cut Could Matter Most Here
Foreign portfolio investors have US$115 billion parked in HDFC Bank, ICICI Bank. If the government cuts long-term capital gains tax, Jefferies says returning foreign money could land here first.
-
'Never Seen This Level Of Negativity': Sandeep Tandon Says The Next Rally May Be Closer Than You Think
Veteran investor Sandeep Tandon says foreign selling is easing, large-caps are due a comeback and mid-caps are crowded, while he turns positive on gold, power and pharma this Diwali.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.